A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

Clinical trial NCT05358379 · UNKNOWN

Trial details

NCT number: NCT05358379
Sponsor: Cyclacel Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Lymphoma

Start date: 2022-04-14
Primary completion: 2025-08-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.